The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
| Revenue (TTM) | $5.81B |
| Gross Profit (TTM) | $909.00M |
| EBITDA | $637.00M |
| Operating Margin | 2.03% |
| Return on Equity | -93.80% |
| Return on Assets | 2.49% |
| Revenue/Share (TTM) | $38.66 |
| Book Value | $1.67 |
| Price-to-Book | 12.94 |
| Price-to-Sales (TTM) | 0.55 |
| EV/Revenue | 1.198 |
| EV/EBITDA | 20.96 |
| Quarterly Earnings Growth (YoY) | -64.60% |
| Quarterly Revenue Growth (YoY) | -2.10% |
| Shares Outstanding | $150.11M |
| Float | $149.28M |
| % Insiders | 0.31% |
| % Institutions | 91.26% |
Volatility is currently contracting